Search

Tadimeti Seetapati Rao

from San Diego, CA
Age ~65
Get Report
Also known as:
Tadimeti Seetapati Dr Rao, Tadimeti S Rao, Tadimeti Sectapati Rao, Tadimeti A Rao, Tadimeti Seetapati Rao Dr, T Rao, Rao Tadimeti, Krishna Meduri
Phone and address:
11407 Fairwind Ct, San Diego, CA 92130
(858) 792-7953
Related to:
Srinivas Ayyagari, 44Keshav TadimetiNeel Ayyagari
Connected to:
Adil Rao, 31Ahmed Rao, 36Ajit Rao, 65Akanksha S Rao, 38Akhtar Rao, 51Akshata Rao, 37Aman Rao, 38Amar A Rao, 69Ambarish R Rao, 37Amruta Rao, 37

Tadimeti Rao Phones & Addresses

  • 11407 Fairwind Ct, San Diego, CA 92130 (858) 792-7953
  • 13479 Chelan Ct, San Diego, CA 92129 (858) 484-7411
  • Vista, CA
  • Carlsbad, CA
  • La Jolla, CA
  • Ballwin, MO

Resumes

Resumes

Tadimeti Rao Photo 1

Scientific Director And Fellow

View page
Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Johnson & Johnson 2009 - Jun 2012
Research Fellow, Pharmacology
The Janssen Pharmaceutical Companies of Johnson & Johnson 2009 - Jun 2012
Scientific Director and Fellow
Kalypsys 2003 - Sep 2009
Director, Pharmacology and Preclin Development
Merck 1998 - 2003
Senior Research Fellow
Merck 1993 - 1998
Associate Director
Education:
University of Alberta 1983 - 1986
Doctorates, Doctor of Philosophy, Neuroscience A.u.m.s.n.p.g.centre, Kkd 1980 - 1982
A.u.m.s.n.p.g.centre, Kkd 1975 - 1979
Skills:
Drug Discovery
Pharmacology
Clinical Development
Biotechnology
Neuroscience
Oncology
Pharmaceutical Industry
Pharmacokinetics
Drug Development
Inflammation
Glp
Therapeutic Areas
In Vivo
Cell Culture
Clinical Research
Ind
Clinical Pharmacology
Gpcrs
Dmpk
Research
Mass Spectrometry
High Throughput Screening
Neuropharmacology
Metabolism
Formulation
Neurodegeneration
Program Management
Strategy
Tadimeti Rao Photo 2

Tadimeti Rao

View page

Publications

Us Patents

Piperidine Inhibitors Of Janus Kinase 3

View page
US Patent:
8299084, Oct 30, 2012
Filed:
Apr 20, 2010
Appl. No.:
12/763858
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
Auspex Pharmaceuticals, Inc. - La Jolla CA
International Classification:
A01N 43/90
A61K 31/519
C07D 487/00
US Classification:
5142651, 544280
Abstract:
The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.

Quinolone Inhibitors Of Lipoprotein-Associated Phospholipase A2

View page
US Patent:
8575348, Nov 5, 2013
Filed:
Jul 28, 2010
Appl. No.:
12/845384
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
Auspex Pharmaceuticals, Inc - La Jolla CA
International Classification:
C07D 215/38
US Classification:
546159
Abstract:
The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.

Aminothiazole Modulators Of Beta-3-Adrenoreceptor

View page
US Patent:
8586760, Nov 19, 2013
Filed:
Jun 9, 2010
Appl. No.:
12/796781
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
Auspex Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D 277/20
A61K 31/425
US Classification:
548194, 514370
Abstract:
The present invention relates to new aminothiazole modulators of beta-3-adrenoreceptor activity, pharmaceutical compositions thereof, and methods of use thereof.

Pyrimidinone Inhibitors Of Lipoprotein-Associated Phospholipase A2

View page
US Patent:
8637524, Jan 28, 2014
Filed:
Jul 21, 2010
Appl. No.:
12/840725
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
Auspex Pharmaceuticals, Inc - La Jolla CA
International Classification:
C07D 239/78
A61K 31/517
A61P 11/06
A61P 29/00
A61P 9/10
US Classification:
5142581, 544253
Abstract:
The present invention relates to new pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.

Methods For The Modulation Of Crp By The Selective Modulation Of Ppar Delta

View page
US Patent:
20080004281, Jan 3, 2008
Filed:
Jun 26, 2007
Appl. No.:
11/768887
Inventors:
Tadimeti S. Rao - San Diego CA, US
John P. McKearn - San Diego CA, US
Mausumee Guha - San Diego CA, US
Assignee:
KALYPSYS, INC. - San Diego CA
International Classification:
A61K 31/495
A61K 31/4985
A61P 19/02
US Classification:
514249, 51425212, 51425503
Abstract:
The present invention discloses methods to reduce C-reactive protein (CRP) in patients in need thereof comprising the selective modulation of PPARδ.

Benzimidazole Modulators Of H1 Receptor And/Or Ns4B Protein

View page
US Patent:
20100284970, Nov 11, 2010
Filed:
Apr 9, 2010
Appl. No.:
12/757243
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
AUSPEX PHARMACEUTICALS, INC. - Vista CA
International Classification:
A61K 31/4184
C07D 403/06
A61K 38/21
A61K 31/522
A61K 31/7072
A61K 31/7076
A61K 31/7056
A61K 31/52
A61K 31/675
A61K 31/662
A61P 31/12
A61P 37/08
A61P 17/04
A61P 31/14
US Classification:
424 857, 5483061, 514394, 424 854, 5142633, 514 50, 514 46, 514 43, 51426337, 5142634, 514 86, 514120
Abstract:
The present invention relates to new benzimidazole modulators of H1 receptor activity and/or inhibitors of NS4B protein activity, pharmaceutical compositions thereof, and methods of use thereof.

Indazole Inhibitors Of Tyrosine Kinase

View page
US Patent:
20100291025, Nov 18, 2010
Filed:
Apr 13, 2010
Appl. No.:
12/759389
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
AUSPEX PHARMACEUTICALS, INC. - Vista CA
International Classification:
A61K 31/506
C07D 403/12
A61K 39/395
A61K 31/66
A61K 31/662
A61K 31/7008
A61K 31/655
A61K 31/675
A61K 31/505
A61K 31/519
A61K 31/517
A61K 31/7076
A61K 31/522
A61K 31/7052
A61K 31/52
A61K 31/7068
A61K 31/513
A61K 31/5377
A61K 31/65
A61K 35/74
A61K 38/50
A61K 31/53
A61K 31/565
A61K 38/43
A61K 33/36
A61K 38/20
A61K 31/69
A61P 35/00
A61P 17/06
C12N 5/02
US Classification:
424 852, 544324, 514275, 4241411, 514110, 514115, 514 62, 514151, 514 83, 514274, 514249, 5142651, 51426624, 514 46, 514 47, 5142633, 514 43, 51426337, 514 49, 51425214, 5142664, 5142348, 4241331, 4241421, 4241441, 514154, 424780, 424 946, 514245, 514 77, 514171, 424 941, 424623, 514 64, 5142591, 435375
Abstract:
The present invention relates to new indazole inhibitors of tyrosine kinase activity, pharmaceutical compositions thereof, and methods of use thereof.

Sulfonamide Inhibitors Of Carbonic Anhydrase

View page
US Patent:
20100317655, Dec 16, 2010
Filed:
Jun 4, 2010
Appl. No.:
12/793812
Inventors:
Tadimeti Rao - San Diego CA, US
Chengzhi Zhang - San Diego CA, US
Assignee:
AUSPEX PHARMACEUTICALS, INC. - Vista CA
International Classification:
A61K 31/542
C07D 513/04
A61K 31/5578
A61P 27/02
A61P 27/06
US Classification:
5142265, 544 48
Abstract:
The present invention relates to new sulfonamide inhibitors of carbonic anhydrase activity, pharmaceutical compositions thereof, and methods of use thereof.
Control profile
Tadimeti Seetapati Rao from San Diego, CA, age ~65 Get Report